In the first 2026 episode of Dispatched, we discuss perceptions, Australian health policy, highlighting newly accessible 2005 Cabinet papers and what they reveal about PBS reforms, generic pricing, pharmacy agreements and the influence of central agencies like Finance. They warn that today’s reviews, statutory pricing and cost-recovery debates must be viewed as an interconnected agenda. …
Latest Video
New Stories
-
Pharmac announces plan to revise its recently expanded patient advisory function
August 4, 2026 - - Latest News -
Australian company announces agreement with Lilly to trial lung cancer combination
August 4, 2026 - - Latest News -
The complete absence of patient power and agency makes this a health system outlier
August 4, 2026 - - Latest News -
Arrotex Pharmaceuticals appoints experienced industry executive as CMO
August 4, 2026 - - Latest News -
The risk to patients is that new pricing policies could swamp any benefit from the HTA Review
August 4, 2026 - - Latest News -
Potential merger could create a new global oncology powerhouse
August 3, 2026 - - Latest News -
The HTA Review and the 'Abilene paradox' - when everyone argues for reforms that nobody wants
August 3, 2026 - - Latest News